Under construction – not a live service
Sign in
Not yet taking people in GermanyNo phase

Tests AI tools to help assess kidney and prostate tumors from imaging

Tests an AI platform to support doctors reviewing suspected kidney or prostate cancer.

Plain-language title generated from the registry record
Registry title: Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate

Key facts

Where
Berlin and München, GermanySee the 2 sites

Where in Germany

  • Department of Neuroradiology, ChariteBerlin, GermanyNo longer taking part
  • Klinikum rechts der Isar, TUMMünchen, GermanyNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Aristotle University Of Thessaloniki
Trial code
NCT07888322
Record updated
2 November 2026
Original description
The COMFORT study will evaluate an artificial intelligence-based platform developed to support the clinical assessment of kidney and prostate cancer. The platform utilises imaging data to provide AI-generated outputs intended to assist clinicians in the assessment of suspected lesions.Read full original descriptionShow less

Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate

The COMFORT study will evaluate an artificial intelligence-based platform developed to support the clinical assessment of kidney and prostate cancer. The platform utilises imaging data to provide AI-generated outputs intended to assist clinicians in the assessment of suspected lesions.

The primary objective of the study is to assess the role of the COMFORT platform in the clinical decision making process of clinicians managing kidney or prostate cancer cases.

Secondary objectives include evaluation of the performance of AI models on anatomical segmentations, tumor characterisation (localisation, volumetric measurements, lesion classification, and scoring (e.g., Bosniak, PI-RADS, RENAL). Also the acceptability, usability, utility and trustworthiness of the AI models will be evaluated.

In addition, potential causes of privacy leakage associated with the COMFORT AI models will be evaluated as part of the platform's privacy assessment.

Inclusion: Healthcare professional resident or specialised in Urology; Healthcare professional resident or specialised in Radiology; Proficient in English.

Exclusion: -.

ClinicalTrials.gov NCT07888322